Butrans Transdermal
Links shared publicly online about this topic
Butrans transdermal system approved for chronic pain - MPR
empr.com — “The FDA has approved Purdue's Butrans (buprenorphine) Transdermal System for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time.” View full resource at empr.com
Most Recently Shared on July 1, 2010 at 8:55 pm By:
MPR News: Butrans transdermal system approved for chronic pain: The FDA has approved Purdue's Butrans (buprenorphi... http://bit.ly/avUYDR
Butrans Transdermal System approved for chronic pain - ONA
oncologynurseadvisor.com — “The FDA has approved Purdue--™s Butrans (buprenorphine) Transdermal System for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 1, 2010 at 9:01 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Butrans transdermal system approved for chronic pain http://goo.gl/fb/Pb2Nq
Butrans Transdermal System available soon for chronic pain - MPR
empr.com — “Purdue announced that Butrans (buprenorphine) Transdermal System will be available for ordering the week of January 10, 2011.” View full resource at empr.com
Most Recently Shared on December 1, 2010 at 9:14 pm By:
MPR News: Butrans Transdermal System available soon for chronic pain: Purdue announced that Butrans (buprenorphi... http://bit.ly/dWjNRc
Butrans Transdermal System available soon for chronic pain - ONA
oncologynurseadvisor.com — “Purdue announced that Butrans (buprenorphine) Transdermal System will be available for ordering the week of January 10, 2011.” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 1, 2010 at 9:19 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Butrans Transdermal System available soon for chronic pain http://goo.gl/fb/K0xaA
Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010
news-medical.net — “Purdue Pharma L.P. will present data from the clinical program for Butrans" (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas.” View full resource at news-medical.net
Most Recently Shared on September 10, 2010 at 1:21 pm By:
Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010: Purdue Pharma L.P... http://bit.ly/aUtDKu
Butrans" Approved by FDA for Pain Management
hcplive.com — “Butrans™ (buprenorphine) Transdermal System CIII was approved by the FDA” View full resource at hcplive.com
Most Recently Shared on July 7, 2010 at 4:11 pm By:
Butransâ„¢ Approved by FDA for Pain Management http://hcp.lv/9akcMt
The Efficacy And Safety Of Butrans (buprenorphine) Transdermal System In Opioid-Naive Patients With Moderate To Severe Low Back Pain
medicalnewstoday.com — “Physicians from Purdue Pharma LP, Stamford, CT, showcased study results that demonstrate the analgesic efficacy and safety of Butrans for the relief of moderate to severe chronic low back pain in” View full resource at medicalnewstoday.com
Most Recently Shared on March 26, 2011 at 7:05 am By:
The Efficacy And Safety Of Butrans (buprenorphine) Transdermal System In Opioid-Naive Patients With Moderate To Severe... http://mnt.to/3SMn
BUTRANS - New Product Releases - MPR
empr.com — “Moderate to severe chronic pain when continuous opioid analgesia is needed for extended time period. Not for as-needed use.” View full resource at empr.com
Most Recently Shared on January 7, 2011 at 2:31 pm By:
MPR News: BUTRANS: Buprenorphine 5mcg/hour, 10mcg/hour, 20mcg/hour; transdermal patch. http://bit.ly/hl0PvK
Butrans (Buprenorphine) Transdermal System CIII Pivotal Phase 3 Data Published in the Journal of Pain and Symptom Management - Drugs.com MedNews
drugs.com — “A pivotal Phase 3 study of Butrans (buprenorphine) Transdermal System CIII in opioid-naive patients with moderate-to-severe chronic low back pain demonstrated s” View full resource at drugs.com
Most Recently Shared on October 26, 2011 at 6:02 pm By:
Drugs and Devices OW OW Health
Butrans (Buprenorphine) Transdermal System CIII Pivotal Phase 3 Data Published in the Journal of Pain and ... http://t.co/yjmTMQRA #drug
Chronic Pain - FDA Approves New Pain Patch: Butrans
healthcentral.com — “The FDA has approved Butrans" (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time.” View full resource at healthcentral.com
Most Recently Shared on September 30, 2010 at 9:49 pm By:
Catherine Waters Physician Group
Chronic Pain - FDA Approves New Pain Patch: Butrans http://t.co/OhZlR0p via @AddThis
The Efficacy and Safety of Butrans (buprenorphine) Transdermal System in Opioid-Naive Patients with Moderate to Severe Low Back Pain: A Double-Blind Study - Drugs.com MedNews
drugs.com — “NATIONAL HARBOR, Md., March 25, Physicians from Purdue Pharma LP, Stamford, CT, showcased study results that demonstrate the analgesic efficacy and safety of Bu” View full resource at drugs.com
Most Recently Shared on March 28, 2011 at 7:09 pm By:
Drugs and Devices OW OW Health
The Efficacy and Safety of Butrans (buprenorphine) Transdermal System in Opioid-Naive Patients with Modera... http://bit.ly/h9jzGY #drug
Purdue Pharma L.P. to Present Data From Clinical Program for Butrans(TM) (buprenorphine) Transdermal System CIII at PAINWeek 2010 - Health News - redOrbit
redorbit.com — “STAMFORD, Conn., Sept. 9 /PRNewswire/ -- Purdue Pharma L.P. will present data from the clinical program for Butrans(TM) (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek 2010, September 8-10 in Las Vegas. Butrans recently received marketing approval from the U.S.” View full resource at redorbit.com
Most Recently Shared on September 9, 2010 at 7:19 pm By:
Purdue Pharma L.P. to Present Data From Clinical Program for Butrans(TM) (buprenorphine) Transdermal System CIII a... http://bit.ly/cAAEEW
Nat'l Scientific Psychiatry Mtg: Study Evaluated Vyvanse Efficacy and Safety in Adolescents with ADHD - Drugs.com MedNews
drugs.com — “Nat'l Scientific Psychiatry Mtg: Study Evaluated Vyvanse Efficacy and Safety in Adolescents with ADHD - Drugs.com MedNews” View full resource at drugs.com
Most Recently Shared on June 4, 2010 at 4:32 pm By:
Nat'l Scientific Psychiatry Mtg: Study Evaluated Vyvanse Efficacy and Safety in Adolescents with ADHD: ... (S... http://bit.ly/9keegs #adhd
xho0q - deals and more info
oohja.com — “Find stuff related to 'xho0q' like insides, coupons, and more ...” View full resource at oohja.com
Most Recently Shared on July 7, 2010 at 12:11 pm By:
Dr. Alan Tebby Chiropractor, Doctor, and CAM
Purdue Pharma L.P. Receives FDA Approval For Butrans? (buprenorphine) Transdermal System CIII|Purdue Pharma L.P. .. http://oohja.com/xho0q
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
